发明申请
US20110245200A1 USE OF IDRABIOTAPARINUX FOR DECREASING THE INCIDENCE OF BLEEDINGS DURING AN ANTITHROMBOTIC TREATMENT
审中-公开
使用IDRABIOTAPARINUX减轻抗生素治疗期间出血的发生率
- 专利标题： USE OF IDRABIOTAPARINUX FOR DECREASING THE INCIDENCE OF BLEEDINGS DURING AN ANTITHROMBOTIC TREATMENT
- 专利标题（中）： 使用IDRABIOTAPARINUX减轻抗生素治疗期间出血的发生率
-
申请号： US13003623申请日： 2009-07-17
-
公开(公告)号： US20110245200A1公开(公告)日： 2011-10-06
- 发明人: Roger Cariou , Paul Chew , Jean-Michel Destors , Gérard Pillion , Louise Silvestre
- 申请人： Roger Cariou , Paul Chew , Jean-Michel Destors , Gérard Pillion , Louise Silvestre
- 申请人地址： FR Paris
- 专利权人： SANOFI-AVENTIS
- 当前专利权人： SANOFI-AVENTIS
- 当前专利权人地址： FR Paris
- 优先权： EP08290704.9 20080718; EP09290216.2 20090324
- 国际申请： PCT/IB09/06621 WO 20090717
- 主分类号： A61K31/702
- IPC分类号： A61K31/702 ; A61P9/14 ; A61P7/02
摘要：
The invention relates to the use of idrabiotaparinux for the treatment and secondary prevention of thrombotic pathologies, wherein the use of idrabiotaparinux involves a decrease in the incidence of bleedings, in particular major bleedings, during said treatment.
信息查询
